Skip to content

Insider · CIK 0001511797

Bryan Supran

officer

Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.). First filing Oct 6, 2026, latest Oct 6, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $399k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ALNY: ALNYLAM PHARMACEUTICALS, INC.

ALNYOct 9, 2026 · close 232.68

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
36Weak
ALNYsell
ALNYLAM PHARMACEUTICALS, INC.
$399k
1,758 shares
-12%+7% from low-55% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,758$226.88$399k12,8076 d ago
Oct 1, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+13,026$0.00$013,026Oct 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bryan Supran: insider trades and track record | InsiderTell